Michael Kavanagh named Nanosonics CEO
28 August, 2013Nanosonics (ASX:NAN) director Michael Kavanagh will take over as CEO from October, with current chief Ron Weinberger moving into a new role.
Nominations open for 2013 NSW Science and Engineering Awards
13 August, 2013Scientists, engineers, researchers and teachers are now encouraged to submit nominations for the NSW Science and Engineering Awards.
Modern microscopy addresses an age-old problem
10 July, 2013 by Fiona WylieIn 1959, Nobel prize-winning physicist Richard Feynman wrote: “It is very easy to answer many of these fundamental biological questions; you just look at the thing!” In 2013, Melbourne cell biologist Leann Tilley is doing just that as part of the global fight against malaria … using some very 21st century ways of ‘looking’.
LBT Innovations enters joint venture with Hettich
26 June, 2013 by Dylan Bushell-EmblingLBT Innovations (ASX:LBT) will enter a 50/50 JV with Switzerland’s Hettich to oversee final development and distribution of lab screening platform APAS.
Jumping droplets clean wings
30 April, 2013 by Susan WilliamsonDew drops that randomly collect on the surface of cicada wings provide a free cleaning service.
Nanosonics signs UK distributor for Trophon EPR
18 April, 2013 by Dylan Bushell-EmblingToshiba Healthcare will this month start distributing Nanosonics’ (ASX:NAN) Trophon EPR ultrasound probe disinfection cabinets.
Nanosonics expands reach for Trophon EPR
15 April, 2013 by Dylan Bushell-EmblingNanosonics (ASX:NAN) has ramped up compatibility testing for its ultrasound probe disinfection system, adding 219 products from four vendors to the approved list.
Applikon to buy HaloteC’s biotech portfolio
08 April, 2013Applikon Biotechnology will buy part of the product portfolio of HaloteC Instruments and integrate the instruments and software tech into its bioreactor software offerings.
Abbott spins-off pharmaceutical division into AbbVie
08 January, 2013 by Tim DeanAbbott Laboratories is now two companies, with it spinning-off its pharmaceutical business into a new company, AbbVie.
Graham Kelly back in charge of revamped Novogen
07 December, 2012 by Dylan Bushell-EmblingNovogen (ASX:NRT) has acquired cancer drug developer Triaxial and re-appointed founder Dr Graham Kelly as CEO as it completes a three-year restructuring.
Doors open at Walter and Eliza Hall upgraded $185m facility
22 November, 2012 by Tim DeanPersonalised medicine, translational research, a blood donor register and insectary for researching malaria are all part of an upgraded WEHI facility opened today.
Research Australia Awards 2012
22 November, 2012 by Tim DeanThe Australian health and medical research community gathered to recognised its best and brightest at the Research Australia Awards for 2012.
Comment: Science must advocate its cause or risk losing government support
24 October, 2012 by Staff WritersProfessor Tony Peacock, CEO of the CRC Association, says the government “funding pause” shows even science isn’t immune from politically motivated budget cuts, so scientists must make their case more strongly and more often.
Slideshow: Inner space
23 October, 2012 by Staff WritersThe Nikon Small World winners of 2012 showcase the fantastic world that exists just beyond our perception.
The freeze is over: NHMRC announces funding outcomes
19 October, 2012 by Tim DeanMillions of dollars in long-awaited funding for medical research have finally been allocated with the National Health and Medical Research Council announcing the outcomes key grants.
